<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-INAB1AAU</identifier><date>2010</date><creator>Ocvirk, Janja</creator><relation>documents/znanstveni_clanki/radiology_and_oncology/html/URN_NBN_SI_doc-INAB1AAU.html</relation><relation>documents/znanstveni_clanki/radiology_and_oncology/pdf/URN_NBN_SI_doc-INAB1AAU.pdf</relation><relation>documents/znanstveni_clanki/radiology_and_oncology/txt/URN_NBN_SI_doc-INAB1AAU.txt</relation><format format_type="main">2 strani</format><format format_type="issue">4</format><format format_type="volume">44</format><format format_type="type">article</format><format format_type="extent">str. 265-266</format><identifier identifier_type="COBISSID">1013883</identifier><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-INAB1AAU</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="eng">Antagonists and inhibitors</subject><subject language_type_id="eng">Antibodies, monoclonal</subject><subject language_type_id="slv">cetuximab</subject><subject language_type_id="eng">Colorectal neoplasms</subject><subject language_type_id="eng">drug</subject><subject language_type_id="eng">Drug therapy</subject><subject language_type_id="slv">kožne spremembe</subject><subject language_type_id="slv">onkologija</subject><subject language_type_id="eng">Receptor, epidermal growth factor</subject><subject language_type_id="eng">Skin manifestation</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="eng">Vitamin K1</subject><subject language_type_id="slv">zdravila</subject><subject language_type_id="slv">zdravljenje</subject><title>Management of cetuximab-induced skin toxicity with prophylactic use of topical vitamin K1 cream</title></Record>